These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38218924)
1. Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial. Zhao X; Li X; Liu T; Yang G; Chen Y; Huang M; Zhao L; Li X; Jiang W Trials; 2024 Jan; 25(1):45. PubMed ID: 38218924 [TBL] [Abstract][Full Text] [Related]
2. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial. Zhao X; Chen Y; Yang G; Li X; Tang X; Yang Q; Peng L; Li J; Liang Z; Li A; Wang W; Huang M; Liu T; Li X; Jiang W Am Heart J; 2023 Oct; 264():10-19. PubMed ID: 37276913 [TBL] [Abstract][Full Text] [Related]
3. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Chow CK; Thakkar J; Bennett A; Hillis G; Burke M; Usherwood T; Vo K; Rogers K; Atkins E; Webster R; Chou M; Dehbi HM; Salam A; Patel A; Neal B; Peiris D; Krum H; Chalmers J; Nelson M; Reid CM; Woodward M; Hilmer S; Thom S; Rodgers A Lancet; 2017 Mar; 389(10073):1035-1042. PubMed ID: 28190578 [TBL] [Abstract][Full Text] [Related]
4. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. Bobrie G; Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847 [TBL] [Abstract][Full Text] [Related]
5. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Chow CK; Atkins ER; Hillis GS; Nelson MR; Reid CM; Schlaich MP; Hay P; Rogers K; Billot L; Burke M; Chalmers J; Neal B; Patel A; Usherwood T; Webster R; Rodgers A; Lancet; 2021 Sep; 398(10305):1043-1052. PubMed ID: 34469767 [TBL] [Abstract][Full Text] [Related]
6. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. Bobrie G; Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848 [TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol. Chow CK; Atkins ER; Billot L; Chalmers J; Hillis GS; Hay P; Neal B; Nelson M; Patel A; Reid CM; Schlaich M; Usherwood T; Webster R; Rodgers A Am Heart J; 2021 Jan; 231():56-67. PubMed ID: 33017580 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial. Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R; J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination. Volpe M; Christian Rump L; Ammentorp B; Laeis P Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147 [TBL] [Abstract][Full Text] [Related]
10. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial. Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421 [TBL] [Abstract][Full Text] [Related]
11. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Oparil S; Melino M; Lee J; Fernandez V; Heyrman R Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study. Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study. Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978 [TBL] [Abstract][Full Text] [Related]
15. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study. Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study]. Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study. Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. Kim BJ; Cha KS; Cho WH; Kim EJ; Choi SH; Kim MH; Kim SH; Park JB; Park SM; Sohn IS; Ryu KH; Chae IH J Cardiovasc Pharmacol Ther; 2023; 28():10742484231205204. PubMed ID: 37814541 [TBL] [Abstract][Full Text] [Related]